Literature DB >> 20595680

Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis.

Xiao Ming Meng1, Xiao Ru Huang, Arthur C K Chung, Wei Qin, Xinli Shao, Peter Igarashi, Wenjun Ju, Erwin P Bottinger, Hui Yao Lan.   

Abstract

Smad2 and Smad3 interact and mediate TGF-beta signaling. Although Smad3 promotes fibrosis, the role of Smad2 in fibrogenesis is largely unknown. In this study, conditional deletion of Smad2 from the kidney tubular epithelial cells markedly enhanced fibrosis in response to unilateral ureteral obstruction. In vitro, Smad2 knockdown in tubular epithelial cells increased expression of collagen I, collagen III, and TIMP-1 and decreased expression of the matrix-degrading enzyme MMP-2 in response to TGF-beta1 compared with similarly treated wild-type cells. We obtained similar results in Smad2-knockout fibroblasts. Mechanistically, Smad2 deletion promoted fibrosis through enhanced TGF-beta/Smad3 signaling, evidenced by greater Smad3 phosphorylation, nuclear translocation, promoter activity, and binding of Smad3 to a collagen promoter (COL1A2). Moreover, deletion of Smad2 increased autoinduction of TGF-beta1. Conversely, overexpression of Smad2 attenuated TGF-beta1-induced Smad3 phosphorylation and collagen I matrix expression in tubular epithelial cells. In conclusion, in contrast to Smad3, Smad2 protects against TGF-beta-mediated fibrosis by counteracting TGF-beta/Smad3 signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595680      PMCID: PMC3013519          DOI: 10.1681/ASN.2009121244

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  38 in total

Review 1.  Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis.

Authors:  Anita B Roberts; Fang Tian; Stacey DaCosta Byfield; Christina Stuelten; Akira Ooshima; Shizuya Saika; Kathleen C Flanders
Journal:  Cytokine Growth Factor Rev       Date:  2005-11-11       Impact factor: 7.638

2.  The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells.

Authors:  Mysore K Phanish; Nadia A Wahab; Paul Colville-Nash; Bruce M Hendry; Mark E C Dockrell
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

3.  Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.

Authors:  Fuye Yang; Arthur C K Chung; Xiao Ru Huang; Hui Yao Lan
Journal:  Hypertension       Date:  2009-08-10       Impact factor: 10.190

4.  Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation.

Authors:  Wenjun Ju; Atsushi Ogawa; Joerg Heyer; Dirk Nierhof; Liping Yu; Raju Kucherlapati; David A Shafritz; Erwin P Böttinger
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

5.  Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype.

Authors:  Constance E Runyan; Tomoko Hayashida; Susan Hubchak; Jessica F Curley; H William Schnaper
Journal:  J Biol Chem       Date:  2009-07-20       Impact factor: 5.157

6.  Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice.

Authors:  Arthur C K Chung; Xiao R Huang; Li Zhou; Rainer Heuchel; Kar Neng Lai; Hui Y Lan
Journal:  Nephrol Dial Transplant       Date:  2008-12-18       Impact factor: 5.992

7.  Latent TGF-beta1 protects against crescentic glomerulonephritis.

Authors:  Xiao R Huang; Arthur C K Chung; Li Zhou; Xiao J Wang; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 10.121

8.  Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.

Authors:  Giovanni Latella; Antonella Vetuschi; Roberta Sferra; Valentina Catitti; Angela D'Angelo; Giuliana Zanninelli; Kathleen C Flanders; Eugenio Gaudio
Journal:  Liver Int       Date:  2009-04-28       Impact factor: 5.828

9.  Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling.

Authors:  Marcin Bujak; Guofeng Ren; Hyuk Jung Kweon; Marcin Dobaczewski; Anilkumar Reddy; George Taffet; Xiao-Fan Wang; Nikolaos G Frangogiannis
Journal:  Circulation       Date:  2007-10-22       Impact factor: 29.690

10.  Essential role of Smad3 in angiotensin II-induced vascular fibrosis.

Authors:  Wansheng Wang; Xiao R Huang; Ellery Canlas; Kazuhiro Oka; Luan D Truong; Chuxia Deng; Neil A Bhowmick; Wenjun Ju; Erwin P Bottinger; Hui Y Lan
Journal:  Circ Res       Date:  2006-03-23       Impact factor: 17.367

View more
  125 in total

Review 1.  TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.

Authors:  Rohan Samarakoon; Jessica M Overstreet; Stephen P Higgins; Paul J Higgins
Journal:  Cell Tissue Res       Date:  2011-06-04       Impact factor: 5.249

2.  GQ5 Hinders Renal Fibrosis in Obstructive Nephropathy by Selectively Inhibiting TGF-β-Induced Smad3 Phosphorylation.

Authors:  Jun Ai; Jing Nie; Jiangbo He; Qin Guo; Mei Li; Ying Lei; Youhua Liu; Zhanmei Zhou; Fengxin Zhu; Min Liang; Yongxian Cheng; Fan Fan Hou
Journal:  J Am Soc Nephrol       Date:  2014-11-12       Impact factor: 10.121

3.  Store-operated calcium entry suppressed the TGF-β1/Smad3 signaling pathway in glomerular mesangial cells.

Authors:  Sarika Chaudhari; Weizu Li; Yanxia Wang; Hui Jiang; Yuhong Ma; Mark E Davis; Jonathan E Zuckerman; Rong Ma
Journal:  Am J Physiol Renal Physiol       Date:  2017-06-21

4.  Blockade of ALK4/5 signaling suppresses cadmium- and erastin-induced cell death in renal proximal tubular epithelial cells via distinct signaling mechanisms.

Authors:  Kota Fujiki; Hisako Inamura; Takeshi Sugaya; Masato Matsuoka
Journal:  Cell Death Differ       Date:  2019-02-25       Impact factor: 15.828

5.  Kindlin-2: a new player in renal fibrogenesis.

Authors:  Raimund Hirschberg
Journal:  J Am Soc Nephrol       Date:  2013-07-11       Impact factor: 10.121

6.  Differential expression and therapeutic efficacy of microRNA-346 in diabetic nephropathy mice.

Authors:  Yong Zhang; Hou-Qin Xiao; Yang Wang; Zhuo-Shun Yang; Long-Jun Dai; Yan-Cheng Xu
Journal:  Exp Ther Med       Date:  2015-04-30       Impact factor: 2.447

Review 7.  TGF-β: the master regulator of fibrosis.

Authors:  Xiao-Ming Meng; David J Nikolic-Paterson; Hui Yao Lan
Journal:  Nat Rev Nephrol       Date:  2016-04-25       Impact factor: 28.314

8.  IPF pathogenesis is dependent upon TGFβ induction of IGF-1.

Authors:  Danielle M Hernandez; Jeong-Han Kang; Malay Choudhury; Mahefatiana Andrianifahanana; Xueqian Yin; Andrew H Limper; Edward B Leof
Journal:  FASEB J       Date:  2020-02-17       Impact factor: 5.191

9.  Mutant p53 promotes tumor cell malignancy by both positive and negative regulation of the transforming growth factor β (TGF-β) pathway.

Authors:  Lei Ji; Jinjin Xu; Jian Liu; Ali Amjad; Kun Zhang; Qingwu Liu; Lei Zhou; Jianru Xiao; Xiaotao Li
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

10.  P311 promotes renal fibrosis via TGFβ1/Smad signaling.

Authors:  Zhihui Yao; Sisi Yang; Weifeng He; Lian Li; Rui Xu; Xiaorong Zhang; Haisheng Li; Rixing Zhan; Wei Sun; Jianglin Tan; Junyi Zhou; Gaoxing Luo; Jun Wu
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.